Physician
Dermatology
Dr. Gary D. Monheit, MD
|
|
Give Review
Gary Monheit works in the field of Dermatology. He graduated from University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. He received awards:"Top MD", "Fellow (FAAD)" and "Fellow (FASDS)". Gary D. Monheit, MD has written publications. He has 78 publications published with PubMed. The lastest paper is: 'The etiology of prolonged erythema after chemical peel.' He is registered with Medicare and accepts Medicare payments.
Publications
- Global Aesthetics Consensus: Botulinum Toxin Type A-Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Com...
- Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck-Upper Face (Glabella, Forehead, and Crow's Feet).
- Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study.
- Commentary: mohs micrographic surgery concordance between mohs surgeons and dermatopathologists.
- Commentary: pseudocystic encapsulation: a late noninflammatory complication of hyaluronic Acid filler injections.
- Commentary: Salicylic Acid Peels Versus Jessner's Solution Peels for Acne Vulgaris: A Comparative Study.
- How many sections are required to clear a tumor? Results from a web-based survey of margin thresholds in mohs micrographic surgery.
- Commentary on clinical protocol for punctuated 88% phenol peels in the treatment of photoaging: a histopathologic study of three cases.
- Hyaluronic Acid fillers on the horizon: roundtable discussion.
- Results of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Botulinum Toxin Type A Topical Gel for the Treatment of Modera...
- Commentary: rheological evaluation of the physical properties of hyaluronic Acid dermal fillers.
- An overview of botulinum toxins: past, present, and future.
- Investigator global evaluations of efficacy of injectable poly-L-lactic Acid versus human collagen in the correction of nasolabial fold wrinkles.
- Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles.
- Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings report.
- Facial Soft-Tissue Fillers conference: Assessing the State of the Science.
- Commentary: subcision versus dermal collagen filler for acne Scars.
- Commentary: Complication of CROSS technique on boxcar acne Scars: atrophy.
- Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for low...
- Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) ...
- Development and validation of a 6-point grading scale in patients undergoing correction of nasolabial folds with a collagen implant.
- Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes.
- A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.
- Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial.
- An overview of clinical trial data on a new formulation of botulinum neurotoxin type A.
- The nature of long-term fillers and the risk of complications.
- Comparative physical properties of hyaluronic acid dermal fillers.
- Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler.
- A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds.
- Juvéderm: a hyaluronic acid dermal filler.
- Hyaluronic acid fillers: Hylaform and Captique.
- Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead ...
- Metastatic Skin cancer presenting as ptosis and diplopia.
- Suspension for the aging face.
- Hylaform: a new hyaluronic acid filler.
- Twelve years' experience with the Mohs-Tromovitch technique of Skin cancer removal.
- The etiology of prolonged erythema after chemical peel.
- International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
- International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
- Combination medium-depth peeling: the Jessner's + TCA peel.
- The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel.
- Facial blemishes and their treatment.
- The rhomboid transposition flap re-evaluated.
- The management of malignant and premalignant lesions of the Skin.
- Microscopically controlled surgery: Mohs' chemosurgery for recurrent and aggressive Skin cancer.
- Diagnosis and treatment of Skin cancer. Early diagnosis and cure.
- The Mohs technique in ophthalmic plastic surgery.
- Cancer excision from eyelids and ocular adnexa: the Mohs fresh tissue technique and reconstruction.
- Cancer excision from eyelids and ocular adnexa. The Mohs' fresh tissue technique and reconstruction. A five-year study of 109 patients.
- Angiolymphoid hyperplasia with eosinophilia. The disease and a comparison of treatment modalities.
- Nail surgery.
- Nasal reconstruction with full thickness Skin graft: a cosmetic procedure.
- Mohs micrographic surgery for periorbital Skin cancer.
- The Jessner's + TCA peel: a medium-depth chemical peel.
- Systemic mastocytosis and the mastocytosis syndrome.
- The "modified" winch stitch.
- Medium-depth chemical peels.
- Consultation for photoaging Skin.
- Chemical peels.
- Chemical peeling vs. laser resurfacing.
- Surgical pearl: the winch stitch-a multiple pulley suture.
- A history of chemical peeling.
- A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
- Hyaluronic acid fillers.
- Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.
- Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, ...
- Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: interim analysis from an open-label ex...
- Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines.
- ASDS guidelines of care: injectable fillers.
- Hyaluronic acid fillers for the male patient.
- Soft-tissue filler complications: the important role of biofilms.
- Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.
- Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: results from an 18-month open-label extension trial.
- The performance of MelaFind: a prospective multicenter study.
- Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
- Commentary: new treatment for a surgical wrinkle.
- 12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue filler.
Schools
University Of Colorado School Of Medicine
La Co Usc Med Center
University Of Alabama Hospital
University Of Wisconsin Madison
Procedures Preformed
- Acne Surgery
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- Benign Skin Lesion
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Top MD
- Fellow (FAAD)
- Fellow (FASDS)
Education
-
University of Alabama Medical Center -
University of Southern California - LAC+USC Medical Center -
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1942230248 | |
| NPPES Provider LastName | MONHEIT | |
| NPPES Provider FirstName | GARY | |
| NPPES Provider ZIPCode | 352055021 | |
| NPPES Provider State | AL | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1628.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 475.0 | |
| Percent Opioid Claims | 29.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942230248 |
| Last Name Of The Provider | MONHEIT |
| First Name Of The Provider | GARY |
| View All |
Similar Doctors
|
|
Dr. Patricia J. Mercado, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Barry C. Ginsburg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gwendellyn McLean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney M. Robbins, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elizabeth S. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie C. Harper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah L. Hughey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry W. Sampson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Janet Cash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajat Varma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Virginia A. Koubek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole Y. Lee, MD |
|
|
Dr. Lucia V. Seminario, MD |
|
|
Dr. India M. Hill, MD |
|
|
Dr. Ann M. Hill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elias C. Watson III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren V. Graham, MD |
|
|
Dr. Stephanie B. Walsh, MD |
|
|
Dr. Thomas A. Jennings, MD
This Doctor is OpenDoctor Recommended.
|